# Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study)

> **NCT03611790** · NA · COMPLETED · sponsor: **Vesalio** · enrollment: 30 (actual)

## Conditions studied

- Cerebral Vasospasm

## Interventions

- **DEVICE:** NeVa VS

## Key facts

- **NCT ID:** NCT03611790
- **Lead sponsor:** Vesalio
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-19
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03611790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03611790, "Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03611790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*